��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
興能高(6558)
月營收
季盈餘
2025/02/01
61.60元 (興能高股價)
2025/02/01
11.69% (年增率)
67百萬元 (營收)
興能高(6558) 年度營收走勢圖
興能高(6558)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/02
67,303
-35.53%
60,260
11.69%
171,702
14.71%
114/01
104,399
-0.69%
89,426
16.74%
104,399
16.74%
113/12
105,129
18.21%
86,686
21.28%
1,159,274
-3.13%
113/11
88,935
-4.01%
94,468
-5.86%
1,054,145
-5.04%
113/10
92,648
-16.07%
100,168
-7.51%
965,210
-4.96%
113/09
110,384
-2.60%
106,736
3.42%
872,562
-4.68%
113/08
113,334
4.87%
117,353
-3.42%
762,178
-5.75%
113/07
108,076
6.36%
111,501
-3.07%
648,844
-6.15%
113/06
101,617
20.01%
113,261
-10.28%
540,768
-6.74%
113/05
84,676
-12.13%
93,432
-9.37%
439,151
-5.88%
113/04
96,366
-11.12%
78,463
22.82%
354,475
-5.00%
113/03
108,423
79.93%
97,855
10.80%
258,109
-12.41%
113/02
60,260
-32.61%
90,994
-33.78%
149,686
-23.95%
113/01
89,426
3.16%
105,824
-15.50%
89,426
-15.50%
112/12
86,686
-8.24%
66,761
29.85%
1,196,741
4.21%
112/11
94,468
-5.69%
90,698
4.16%
1,110,055
2.63%
112/10
100,168
-6.15%
96,478
3.82%
1,015,587
2.49%
112/09
106,736
-9.05%
89,939
18.68%
915,419
2.34%
112/08
117,353
5.25%
100,562
16.70%
808,683
0.52%
112/07
111,501
-1.55%
116,104
-3.96%
691,330
-1.80%
112/06
113,261
21.22%
134,431
-15.75%
579,829
-1.37%
112/05
93,432
19.08%
129,372
-27.78%
466,568
2.89%
112/04
78,463
-19.82%
19,295
306.65%
373,136
15.14%
112/03
97,855
7.54%
101,517
-3.61%
294,673
-3.31%
112/02
90,994
-14.01%
70,114
29.78%
196,818
-3.17%
112/01
105,824
58.51%
133,144
-20.52%
105,824
-20.52%
111/12
66,761
-26.39%
135,565
-50.75%
1,148,415
-32.08%
111/11
90,698
-5.99%
109,320
-17.03%
1,081,654
-30.45%
111/10
96,478
7.27%
108,337
-10.95%
990,956
-31.47%
111/09
89,939
-10.56%
139,706
-35.62%
894,478
-33.13%
111/08
100,562
-13.39%
140,528
-28.44%
804,539
-32.84%
111/07
116,104
-13.63%
150,643
-22.93%
703,977
-33.42%
111/06
134,431
3.91%
115,708
16.18%
587,873
-35.17%
111/05
129,372
570.49%
144,248
-10.31%
453,442
-42.68%
111/04
19,295
-80.99%
162,240
-88.11%
324,070
-49.90%
111/03
101,517
44.79%
191,504
-46.99%
304,775
-37.10%
111/02
70,114
-47.34%
97,825
-28.33%
203,258
-30.64%
111/01
133,144
-1.79%
133,144
110/12
135,565
24.01%
1,690,851
110/11
109,320
0.91%
1,555,286
110/10
108,337
-22.45%
1,445,966
110/09
139,706
-0.58%
1,337,629
110/08
140,528
-6.71%
1,197,923
110/07
150,643
30.19%
1,057,395
110/06
115,708
-19.79%
906,752
110/05
144,248
-11.09%
791,044
110/04
162,240
-15.28%
646,796
110/03
191,504
95.76%
484,556
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
